MX9605713A - Procedimiento para preparar un derivado de acetoxiazetidinona e intermedio del mismo. - Google Patents

Procedimiento para preparar un derivado de acetoxiazetidinona e intermedio del mismo.

Info

Publication number
MX9605713A
MX9605713A MX9605713A MX9605713A MX9605713A MX 9605713 A MX9605713 A MX 9605713A MX 9605713 A MX9605713 A MX 9605713A MX 9605713 A MX9605713 A MX 9605713A MX 9605713 A MX9605713 A MX 9605713A
Authority
MX
Mexico
Prior art keywords
group
substituted
atom
iii
sulfide
Prior art date
Application number
MX9605713A
Other languages
English (en)
Other versions
MXPA96005713A (es
Inventor
Hiroshi Ohmizu
Masahiko Seki
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of MXPA96005713A publication Critical patent/MXPA96005713A/es
Publication of MX9605713A publication Critical patent/MX9605713A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30—Preparation of optical isomers
    • C07C227/32—Preparation of optical isomers by stereospecific synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/93—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/08—1,3-Thiazines; Hydrogenated 1,3-thiazines condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C07F7/1872—Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

Un compuesto de N-[2-1-hidroxietil)-3-oxopropil]amina de la formula [III] (Ver formula); en donde el anillo B representa un anillo de benceno que puede substituirse; W representa átomo de oxígeno o átomo de sulfuro; Y representaátomo de oxígeno, átomo de sulfuro o NR., R?? representa átomo de hidrogeno o un substituido; Z representa un grupo metileno substituido que contiene por lo menos un centro quiral; R5 representa un grupo aralquiloxicarbonilo o un grupo alcoxicarbonilo; R6 representa átomo de hidrogeno, un grupo aralquilo, un grupo aciloxi, un grupo sililoxi tri-substituido o un grupo alcoxi; o ambos R5 y R6 se unen en sus extremos y se combinan con el átomo de nitrogeno adyacente para formar grupo ftalimido, y un procedimiento de los mismos se describen; dicho compuesto [III] es util como un compuesto de partida de agentes antibacteriales de beta-lactama.
MX9605713A 1995-11-17 1996-11-18 Procedimiento para preparar un derivado de acetoxiazetidinona e intermedio del mismo. MX9605713A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP299524/1995 1995-11-17
JP7-299524 1995-11-17
JP7299524A JPH09143156A (ja) 1995-11-17 1995-11-17 アセトキシアゼチジノン誘導体の製法及びその合成中間体

Publications (2)

Publication Number Publication Date
MXPA96005713A MXPA96005713A (es) 1997-06-01
MX9605713A true MX9605713A (es) 1997-06-28

Family

ID=17873715

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9605713A MX9605713A (es) 1995-11-17 1996-11-18 Procedimiento para preparar un derivado de acetoxiazetidinona e intermedio del mismo.

Country Status (7)

Country Link
US (1) US5831091A (es)
EP (1) EP0774463A1 (es)
JP (1) JPH09143156A (es)
KR (1) KR970027059A (es)
CA (1) CA2190408A1 (es)
MX (1) MX9605713A (es)
SG (1) SG44059A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5479743A (en) * 1994-07-28 1996-01-02 Queen; Lorne Inflatable emergency shelter
US7192944B2 (en) * 2003-03-07 2007-03-20 Schering Corp. Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
ATE406364T1 (de) 2003-03-07 2008-09-15 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
CN1756756A (zh) 2003-03-07 2006-04-05 先灵公司 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
CN101177416B (zh) * 2006-11-06 2011-06-08 上海医药工业研究院 (2’s,3’r,4s)-3-[2’-(n-取代氨甲基)-3’-羟基丁酰基]-4-取代噁唑烷-2-酮衍生物及其制备方法
CN115057796A (zh) * 2015-12-01 2022-09-16 焦作健康元生物制品有限公司 光学活性的β-羟基酯类化合物的中间体

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2943087A (en) * 1960-06-28 n naoh
DE1770482A1 (de) * 1968-05-22 1971-11-11 Basf Ag Verfahren zur Herstellung von 2,4-Dioxychinolinen
FR2055001A5 (es) * 1969-07-14 1971-05-07 Aubing Chem Fab
IE66711B1 (en) * 1988-04-01 1996-01-24 Sankyo Co 2-(heterocyclylthio) carbapenem derivatives their preparation and their use as antibiotics
EP0371875B1 (en) * 1988-11-29 1994-12-28 Takasago International Corporation Process for preparing 4-acetoxyazetidinones
JP2640986B2 (ja) * 1990-11-08 1997-08-13 高砂香料工業株式会社 （１′ｒ，３ｓ）―３―（１′―ヒドロキシエチル）―アゼチジン―２―オン又はその誘導体の製造法
JP2969387B2 (ja) * 1991-04-18 1999-11-02 高砂香料工業株式会社 置換アセトキシアゼチジノン類及び４−アシルオキシアゼチジノン類の製造方法
JPH05239019A (ja) * 1992-02-27 1993-09-17 Takasago Internatl Corp ２−アゼチジノン誘導体の製造方法
US5442055A (en) * 1992-11-13 1995-08-15 Tanabe Seiyaku Co., Ltd. Azetidinone compound and process for preparation thereof
US5550229A (en) * 1993-06-23 1996-08-27 Tanabe Seiyaku Co., Ltd. Alkylation process for preparing azetidinone compound and starting compound therefor
EP0632037B1 (en) * 1993-06-30 1997-10-01 Tanabe Seiyaku Co., Ltd. Process for the production of 4-substituted azetidinone derivatives

Also Published As

Publication number Publication date
SG44059A1 (en) 1997-11-14
JPH09143156A (ja) 1997-06-03
CA2190408A1 (en) 1997-05-18
KR970027059A (ko) 1997-06-24
US5831091A (en) 1998-11-03
EP0774463A1 (en) 1997-05-21

Similar Documents

Publication Publication Date Title
TW359670B (en) Process for producing quinazolin-4-one derivatives
TR200003332T2 (tr) İzoksazolin-3-il-asil benzen üretmek için yöntem
DE69930947D1 (de) Piperazin-4-phenyl-derivate als inhibitoren der wechselwirkung zwischen mdm2 und mdm2
WO2004046113A3 (en) Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors
CA2212007A1 (en) Pyridonecarboxylic acid derivatives substitued by a bicyclic amino group
MX9700871A (es) Procedimiento para hacer compuestos antimicrobianos.
AU6241894A (en) 4-alkoxy-2,6-di-t-butylphenol derivative
TNSN07357A1 (en) Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
IE862630L (en) 3-VINYL AND 3-ETHYNYL-ß-CARBOLINES
MX9605713A (es) Procedimiento para preparar un derivado de acetoxiazetidinona e intermedio del mismo.
HUP0200144A2 (hu) Eljárás peszticid hatású 5-amino-1-aril-3-cianopirazol-származékok előállítására és az új köztitermékek
CA2221946A1 (en) Production process of cyclic compound
EA199901050A3 (ru) Новые соединения имидазолина, способ их получения и содерщащие их фармацевтические композиции
ES8105704A1 (es) Procedimiento de preparacion de nuevos eteres oximas, de sussales de adicion acidas y de sus derivados amonicos cuater- narios
ATE375343T1 (de) Neue beta-lactamverbindungen und verfahren zu deren herstellung
AU703163B2 (en) Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions
BR9600979A (pt) Composto processo para combater fungos fitopatogênicos composição fungicida e processo de preparação de um composto
CA2284646A1 (en) Synthesis of intermediates useful in preparing tricyclic compounds
DE69708640T2 (de) Pyridoncarbonsäure-derivate und zwischenverbindungen für deren herstellung
EP0781773A4 (en) NEW CARBAPENEM DERIVATIVES
MX9504041A (es) 3-[4-(1-substituido-4-piperazinil)butil]-4-tiazolidinona y compuestos relacionados.
MX9604347A (es) Derivados del acido 2-(4-pirazoliloxi-pirimidin-5-il) acetico.